Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2010
08/10/2010CA2391832C Oral dosage forms
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2250309C Steroids as neurochemical initiators of change in human blood levels of lh or fsh
08/10/2010CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals
08/05/2010WO2010088700A1 Methods for improving cognitive function and decreasing heart rate
08/05/2010WO2010088455A2 Cromolyn derivatives and related methods of imaging and treatment
08/05/2010WO2010088414A2 Subunit selective nmda receptor potentiators for the treatment of neurological conditions
08/05/2010WO2010087771A1 Compound and method for treatment of alzheimer's disease
08/05/2010WO2010087762A1 2-aza-bicyclo[2.2.1]heptane compounds and uses thereof
08/05/2010WO2010087761A1 2-aza-bicyclo[2.2.2]octane compounds and uses thereof
08/05/2010WO2010087693A1 Composition comprising oil palm phenolics for use in providing neuroprotective effects and cognitive-enhancement
08/05/2010WO2010087480A1 Pharmaceutical preparation or food containing peptide
08/05/2010WO2010087454A1 Quinoline derivative
08/05/2010WO2010087399A1 Urotensin-ii receptor antagonists
08/05/2010WO2010087315A1 Anti-alzheimer’s disease agent
08/05/2010WO2010087313A1 Neurite elongation stimulator
08/05/2010WO2010087306A1 Anti-neurodegenerative disease agent
08/05/2010WO2010087244A1 Cyclic amino alcohol compound
08/05/2010WO2010086972A1 Antistress agent
08/05/2010WO2010086864A1 Methods and compositions for treating alzheimer's disease
08/05/2010WO2010086828A2 Agonist anti-trkb monoclonal antibodies
08/05/2010WO2010086484A1 Use of derivates of 6-substituted 3-phenylcoumarins and preparation of new derivates
08/05/2010WO2010086454A1 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes, cardiovascular diseases and other adiponectin-related diseases
08/05/2010WO2010086403A1 Azetidines as histamine h3 receptor antagonists
08/05/2010WO2010086280A1 Novel n-oxides of furanyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
08/05/2010WO2010086279A1 Novel dibenzofuranyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
08/05/2010WO2010086278A1 Novel benzodioxolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
08/05/2010WO2010086259A1 Piperidine derivatives as nk3 receptor antagonists
08/05/2010WO2010085848A1 Drug abuse deterrent, methods and compositions
08/05/2010WO2010066931A4 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
08/05/2010WO2010063470A3 Methods for preventing or reducing colon carcinogenesis
08/05/2010WO2010031056A3 Methods and compositions for modulating ire1, src, and abl activity
08/05/2010WO2010023512A8 Novel vanilloid receptor modulators, process for their preparation and pharmaceutical compositions containing them
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100199362 Wnt ligands involved in blood-brain barrier development and uses therefor
08/05/2010US20100199361 Role of Proteoglycans in Drug Dependence
08/05/2010US20100197953 Levodopa prodrugs, and compositions and uses thereof
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197907 Phosphorus-containing compounds & uses thereof
08/05/2010US20100197799 Hydroxylamine derivatives
08/05/2010US20100197796 Use of milnacipran or salt, excludes administering phenylalanine, tyrosine, or tryptophan
08/05/2010US20100197785 Omega-3 fatty acid fortified composition
08/05/2010US20100197784 Novel curcumin analogues and uses thereof
08/05/2010US20100197778 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
08/05/2010US20100197777 Synergistic combination of analgesic compounds
08/05/2010US20100197775 Methods and compositions for treating & diagnosing mood disorders, schizophrenia, and neuro-psychiatric disorders
08/05/2010US20100197760 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
08/05/2010US20100197755 Hydrazone modulators of cannabinoid receptors
08/05/2010US20100197744 Organic Compounds
08/05/2010US20100197740 Method of Screening Compounds Having Anti-Amyloid Properties
08/05/2010US20100197735 Novel phenylurea inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
08/05/2010US20100197733 Pyrrolidines and piperidines as orexin receptor antagonists
08/05/2010US20100197730 Methods for treating anxiety
08/05/2010US20100197729 Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds
08/05/2010US20100197725 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
08/05/2010US20100197724 6.5 -pyrrolopiperidine tachykinin receptor antagonists
08/05/2010US20100197723 Bicyclic compounds and methods of making and using same
08/05/2010US20100197721 PYRROLO [3, 4-h] ISOQUINOLINE COMPOUNDS AND METHODS FOR MODULATING GATED ION CHANNELS
08/05/2010US20100197717 Treatment of pain, neuropathic pain, sleep disorders, psychological disorders, memory disorders, depression, jet lag; 5HT7 receptor ligand such as AS-19, aka (2S)-(+)-8-(1,3,5-trimethylpyrazolin-4-yl)-2-(dimethylamino)tetralin and opioid such as morphine
08/05/2010US20100197715 Piperidine derivatives
08/05/2010US20100197714 Spiro-pyrano-pyrazole derivatives
08/05/2010US20100197712 Use of dopamine stabilizers
08/05/2010US20100197708 Indole compounds
08/05/2010US20100197706 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics
08/05/2010US20100197704 Pharmaceutical compositions and method for treating acute mania
08/05/2010US20100197703 N-sulfonyl thiazolylpiperazine derivatives and related n-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases
08/05/2010US20100197700 5-ht7 receptor antagonists
08/05/2010US20100197699 I-OXA-3-Azaspiro (4.5) Decan-2-One And 1-OXA-3, 8-Diazaspiro (4.5) Decan-2-One Derivatives For The Treatment of Eating Disorders
08/05/2010US20100197697 Piperidine derivatives as nk3 receptor antagonists
08/05/2010US20100197693 Novel benzenesulfonamides as calcium channel blockers
08/05/2010US20100197688 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
08/05/2010US20100197685 Novel benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof
08/05/2010US20100197684 Substituted heterocyclic compounds
08/05/2010US20100197681 Triazolopyridine Compounds and Their Use as Ask Inhibitors
08/05/2010US20100197673 Indole and indazole compounds as an inhibitor of cellular necrosis
08/05/2010US20100197670 Amidine, thiourea and guanidine derivatives of 2-aminobenzothiazoles and aminobenzothiazines for their use as pharmacological agents for the treatment of neurodegenerative pathologies
08/05/2010US20100197669 Kappa selective opioid receptor antagonist
08/05/2010US20100197668 1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE AND 2,3,4,5-TETRAHYDROPYRROLO[1,2-a][1,4]-DIAZEPINE-7-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
08/05/2010US20100197666 (thio) -carbamoyl-cyclohexane derivatives and method for treating schizophrenia
08/05/2010US20100197664 Novel b1-antagonists
08/05/2010US20100197660 Azepine derivatives as gamma-secretase inhibitors
08/05/2010US20100197657 2-aryl or heteroaryl indole derivatives
08/05/2010US20100197654 Triazine kinase inhibitors
08/05/2010US20100197652 Pyridine carboxamide orexin receptor antagonists
08/05/2010US20100197651 Pyridazinone compounds
08/05/2010US20100197641 Formulation for lipophilic agents
08/05/2010US20100197635 Treatment of tardive dyskinesia with pyridoxal 5'-phosphate
08/05/2010US20100197628 Methods of treating psychiatric, substance abuse, and other disorders using combinations containing omega-3 fatty acids
08/05/2010US20100197626 Biomarkers for Depression and Methods Using the Same
08/05/2010US20100197622 Non-Peptide Macrocyclic Histone Deacetylase (HDAC) Inhibitors and Methods of Making and Using Thereof
08/05/2010US20100197615 Synthesis of compounds useful as modulators of amyloid-beta production
08/05/2010US20100197610 Fructose 1, 6 bisphosphate - a novel anticonvulsant drug
08/05/2010US20100197608 Use of melanotrophin-potentiating factor as a therapeutic agent
08/05/2010US20100197605 Therapeutic use of peptide yglf and combination with kvlpvpq
08/05/2010US20100197604 Use of peptide as a therapeutic agent
08/05/2010US20100197603 Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections
08/05/2010US20100197602 Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection
08/05/2010US20100197601 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection
08/05/2010US20100197600 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh as a therapeutic agent
08/05/2010US20100197599 Use of a peptide as a therapeutic agent
1 ... 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 ... 1833